Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
AMCP developed this first-of-its-kind report focused on the managed care pharmacy workforce. The objectives of this report are threefold: to describe the composition of the workforce, to serve as a valuable resource f or individuals and organizations, and to capture pharmacists’ perspectives on key workforce-related issues. The 2025 Managed Care Pharmacy Workforce Report represents a significant step toward a deeper understanding of the managed care pharmacy landscape.
On Saturday, October 11, Governor Gavin Newsom signed SB 41, a bill that limits certain business practices employed by pharmacy benefit managers (PBMs) in California. This bill follows previous attempts by the governor to regulate PBMs, including changes implemented in the budget that require PBMs to obtain a license, submit detailed operational and financial statements annually to the Department of Managed Health Care, and act in the best interests of health plans and covered individuals.
The Academy of Managed Care Pharmacy (AMCP) released a first-of-its-kind Managed Care Pharmacy Workforce Report, providing a comprehensive look at the state of the managed care pharmacy profession.
AMCP developed this first-of-its-kind report focused on the managed care pharmacy workforce. The objectives of this report are threefold: to describe the composition of the workforce, to serve as a valuable resource f or individuals and organizations, and to capture pharmacists’ perspectives on key workforce-related issues. The 2025 Managed Care Pharmacy Workforce Report represents a significant step toward a deeper understanding of the managed care pharmacy landscape.
On September 30, 2025, the White House announced a deal with Pfizer to lower drug costs in line with most-favored nation (MFN) pricing. While specific terms of the agreement have not been disclosed, both Pfizer and the White House issued statements providing a broad outline of the agreement.
Under the current Continuing Resolution passed on March 15, government funding will expire at 12:01 AM ET on the morning of Oct. 1. A Continuing Resolution (CR) extends government funding at existing levels in lieu of passage of a regular appropriations bill—occasionally with minor fiscal changes or additional policy “rider” amendments included—for a predetermined amount of time. Unless Congress reaches a deal on an additional funding package, federal government activities and operations deemed “nonessential” will temporarily cease, while “essential” functions and mandatory spending such as Social Security and Medicare payments will continue under contingency plans determined by federal agencies and the Office of Management and Budget (OMB). Since 1980, there have been 14 government shutdowns, with the longest and most recent shutdown to date occurring from Dec. 22, 2018 – Jan. 25, 2019 under the first Trump administration.
In September 2024, AMCP and Impact Education, LLC, held a virtual Market Insights summit with chief medical and pharmacy officers and other senior health care executives to discuss the management of retinal diseases in patients with diabetes.
As organizations representing public health, patients, family caregivers, and healthcare professionals, we have a clear stake in the availability of vaccines. Vaccines represent one of our most effective tools in preventing disease and improving quality of life, throughout the lifespan. The proceedings and recommendations of the CDC’s ACIP have a huge impact on trust and confidence in vaccines, and in Americans’ ability to access those life-saving vaccines. Recognizing the critical importance of this meeting, we respectfully submit the following recommendations.
